---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-097506"
form_type: "8-K"
ticker: "ESPR"
cik: "0001434868"
company_name: "Esperion Therapeutics, Inc."
filed_at: "2025-10-07T23:59:59+00:00"
generated_at: "2026-05-17T04:25:10.502518+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Esperion posts updated corporate presentation; no specific details provided

## Summary
- Company filed 8-K noting October 2025 corporate presentation posted to investor page.
- Exhibit 99.1 is the corporate presentation, but its content was not disclosed in this filing.
- No financial or strategic updates are available from the filing text or exhibit excerpt.
- Investors should review the presentation at esperion.com/investors-media for material information.

## SEC filing metadata
- accession: 0001104659-25-097506
- form_type: 8-K
- ticker: ESPR
- cik: 0001434868
- company_name: Esperion Therapeutics, Inc.
- filed_at: 2025-10-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434868/000110465925097506/0001104659-25-097506-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434868/000110465925097506/tm2527818d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-097506
- JSON: https://secwatch.observer/filing/0001104659-25-097506.json
- Plain text: https://secwatch.observer/filing/0001104659-25-097506.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.